bwcEDRyQSESiEWT

bwcEDRyQSESiEWT

Where’s the postbox? http://asaquadiver.fr/stmap_62acoqba.html?diphenhydramine.cialis.lipitor best selling viagra LEVERKUSEN (Alliance News) – German pharmaceutical giant Bayer AG (BAYZF.PK, BAYRY.PK, BYR.L) Tuesday said it plans to accelerate the development of five promising drug candidates that are currently undergoing phase I and II clinical studies. The goal is to progress these experimental drugs – in the areas of oncology, cardiology and women’s health – into phase III clinical studies by 2015.

Deixe uma resposta

O seu endereço de e-mail não será publicado. Campos obrigatórios são marcados com *